We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$611M
AUM Growth
+$35.5M
Cap. Flow
+$24.5M
Cap. Flow %
4.01%
Top 10 Hldgs %
19.82%
Holding
859
New
103
Increased
361
Reduced
225
Closed
69

Sector Composition

Rank Sector Weight
1 Real Estate 11.39%
2 Financials 9.91%
3 Healthcare 9.63%
4 Consumer Discretionary 9.52%
5 Industrials 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPST icon
701
Tempest Therapeutics
TPST
$14.8M
$58K 0.01%
+4
New +$91.4K
ZNGA
702
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$58K 0.01%
23,259
+5,259
+29% +$13.1K
UPL
703
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$58K 0.01%
33,000
-10,000
-23% -$4.53K
PWE
704
DELISTED
Penn West Energy Petroleum Ltd
PWE
$58K 0.01%
42,000
-4,700
-10% -$4.68K
ORN icon
705
Orion Group Holdings
ORN
$514M
$55K 0.01%
+10,335
New +$54K
RXDX
706
DELISTED
Ignyta, Inc.
RXDX
$54K 0.01%
+10,000
New +$66.5K
CCM
707
Concord Medical Services
CCM
$18.7M
$53K 0.01%
+1,379
New +$58.7K
NSLR
708
Neostellar Capital Corp
NSLR
$262M
$51K 0.01%
12,145
S
709
DELISTED
Sprint Corporation
S
$50K 0.01%
11,100
-1,000
-8% -$3.7K
CBR
710
DELISTED
CIBER Inc.
CBR
$47K 0.01%
31,400
+11,000
+54% +$18.7K
AST
711
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$47K 0.01%
19,500
+6,000
+44% +$21.7K
ZVRA icon
712
Zevra Therapeutics
ZVRA
$563M
$46K 0.01%
+719
New +$118K
TROX icon
713
Tronox
TROX
$995M
$45K 0.01%
+10,200
New +$57.9K
GNCA
714
DELISTED
Genocea Biosciences, Inc.
GNCA
$45K 0.01%
+1,366
New +$50.1K
UTSI icon
715
UTStarcom
UTSI
$22.7M
$44K 0.01%
5,784
-3,350
-37% -$26.3K
VHC icon
716
VirnetX Holding Corp
VHC
$52.3M
$44K 0.01%
+550
New +$50.4K
WSCI
717
DELISTED
WSI Industries Inc
WSCI
$44K 0.01%
14,700
-2,250
-13% -$6.73K
CALA
718
DELISTED
Calithera Biosciences, Inc
CALA
$43K 0.01%
+575
New +$57.6K
ABUS icon
719
Arbutus Biopharma
ABUS
$865M
$42K 0.01%
+12,000
New +$50.8K
TOVX icon
720
Theriva Biologics
TOVX
$10.2M
$40K 0.01%
3
LIME
721
DELISTED
LIME ENERGY CO.NEW COMMON STOCK
LIME
$40K 0.01%
17,935
+6,440
+56% +$16.4K
IMGN
722
DELISTED
Immunogen Inc
IMGN
$39K 0.01%
+12,666
New +$79.4K
RAS
723
DELISTED
RAIT Financial Trust
RAS
$39K 0.01%
12,494
+186
+2% +$568
GNW icon
724
Genworth Financial
GNW
$3.8B
$37K 0.01%
14,250
HSTO
725
DELISTED
Histogen Inc. Common Stock
HSTO
$37K 0.01%
90
+23
+34% +$11.3K

Similar funds

Wedbush Securities's Q2 2016 Portfolio in Review

As of Q2 2016, Wedbush Securities held 859 positions worth $611M, up 6.2% from $575M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Wedbush Securities deployed $24.5M of net new capital in Q2 2016, opening 103 new positions and adding to 361 existing holdings. Its largest new stake was KapStone Paper and Pack Corp.: 39,100 shares worth $509K.

By sector, the portfolio is most concentrated in Real Estate at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Total Stock Market ETF, an estimated $1.95M trimmed.

  • Wedbush Securities's largest Q2 2016 buy was KapStone Paper and Pack Corp.: 39,100 shares worth $509K.
  • Wedbush Securities added most to Apple in Q2 2016, an estimated $1.45M increase.
  • Wedbush Securities's biggest Q2 2016 reduction was Vanguard Total Stock Market ETF, cutting an estimated $1.95M.
  • Wedbush Securities fully exited Axos Financial in Q2 2016, selling an estimated $613K.
  • Wedbush Securities's ten largest holdings make up 20% of its $611M portfolio in Q2 2016.
  • Wedbush Securities opened 103 new positions and closed 69 in Q2 2016.
  • Wedbush Securities's portfolio value rose 6.2% quarter-over-quarter to $611M.

Based on Wedbush Securities's 13F filing for Q2 2016, filed 2 Aug 2016.